Indacaterol, one of the active ingredients of ULTIBRO BREEZHALER 110/50, belongs to the class of long-acting beta2- agonists. Long-acting beta2-adrenergic agonists may increase the risk of asthma-related serious adverse events, including asthma-related deaths, when used for the treatment of asthma.